Uses of Danircap 300

Danircap 300mg is an antibiotic used to treat mild to moderate infections caused by susceptible bacteria. The drug is prepared in the form of hard capsules, box of 1 blister x 4 tablets. Before using the drug Danircap 300, patients need to understand the use, consult a doctor to know the dose and unwanted effects.

1. Uses of Danircap 300mg


Danircap 300 drug has the main ingredient Cefdinir, belongs to the 3rd generation Cephalosporin antibiotic group with bactericidal effect, stable even against bacteria containing beta-lactamase enzymes. Danircap 300mg is used to treat upper and lower respiratory tract infections, mild and uncomplicated infections of the skin or soft tissue.
As a broad-spectrum antibiotic, Cefdinir is active against most groups of bacteria such as:
Gram-positive aerobic bacteria: staphylococci, including beta-lactamase-containing strains; pneumococcal, streptococci Gram-negative aerobic bacteria: Moraxella catarrhalis, Haemophilus influenzae, Haemophilus parainfluenzae, including beta-lactamase-containing strains. Gram-positive anaerobes: Staphylococcus epidermidis, Streptococcus agalactiae, Viridan group streptococcus. Gram-negative anaerobes: Proteus mirabilis, Citrobacter diversus, Escherichia coli, Klebsiella pneumonia. However, Cefdinir is not effective against bacteria such as Enterococcus, Enterobacter, blue pus bacilli or methicillin-resistant staphylococcus.

2. Indications and contraindications of the drug Danircap 300mg


Danircap 300mg is indicated for the treatment of infections caused by susceptible bacteria including:
Mild to moderate infections of the upper and lower respiratory tract, including: community-acquired pneumonia, exacerbation of pneumonia chronic management Acute otitis media. Acute maxillary sinusitis. Pharyngitis, tonsillitis. Uncomplicated and mild to moderate skin and soft tissue infections. Danircap 300 mg should not be used in patients with a history of hypersensitivity to cefdinir, other drugs of the cephalosporin group or penicillin allergy.

3. Dosage and how to use Danircap 300mg


The drug Danircap is used orally. Patients should take the entire Danircap 300mg tablet, do not chew, break or crush it because it can reduce the effectiveness of the drug. Danircap can be taken before or after a meal.
Dosage for adults and children from 13 years of age and older:
Pharyngitis, tonsillitis: 300mg/time x 2 times/day for 5 - 10 days or 600mg/time x 1 time/day for 10 days. Community-acquired pneumonia: 300mg/time x 2 times/day, treatment for 10 days Acute exacerbation of chronic bronchitis: 300mg/time x 2 times/day for 5-10 days or 600mg/time x 1 time/day for 10 days day. Acute maxillary sinusitis: 300mg/time x 2 times/day or 600mg/time x 1 time/day for 10 days. Skin infections: 300 mg/time x 2 times/day for 10 days. Children: from 6 months to 12 years: Dosage 14mg/kg/day, maximum 600mg/day.
Specific:
Acute otitis media, acute maxillary sinusitis: 7mg/kg x 2 times/day for 5-10 days or 14mg/kg/time/day for 10 days. Pharyngitis, tonsillitis: 7mg/kg x 2 times/day for 5-10 days or 14mg/kg/time/day for 10 days. Skin and soft tissue infections: 7mg/kg x 2 times/day for 10 days. Patients with impaired liver function, as shown by creatinine clearance < 30ml/min:
Adults: 300mg/time/day. Children: 7mg/kg/time/day (maximum 300mg). Hemodialysis patients:
Initial dose in adults: 300mg/time 2 times a day. Children: 7mg/kg/time 2 times a day.

4. Side effects of the drug Danircap 300mg


Some patients may experience unwanted side effects such as: Nausea, vomiting, diarrhea, rash, urticaria, itching, headache, vaginitis,...
Before prescribing the drug Danircap 300, the doctor weighed the benefits against the risk of side effects. However, side effects can still occur in some patients. When experiencing the above symptoms, the patient should notify the doctor for appropriate treatment instructions.

5. Interactions of the drug Danircap 300mg


Danircap drug can interact if used concurrently with the following drugs:
Antacids or iron-containing drugs: reduce the absorption of Cefdinir. If it is necessary to take two drugs at the same time, they should be taken at least 2 hours apart. Probenecid: reduces the renal excretion of Cefdinir, so it increases the concentration of Danircap in the blood plasma, thereby prolonging the duration and effects of the drug.

6. How to handle when forgetting/overdosing Danircap 300mg


It is important that the patient strictly follow the doctor's instructions, should not forget the medicine. In case you have just missed a dose, you should take it as soon as you remember it. However, if it is almost time for the next dose, take the next dose as indicated, do not take a double dose. Symptoms of overdose of Cefdinir in particular as well as of Cephalosporins in general are usually: vomiting, nausea, upper abdominal pain. If a patient has any symptoms after taking an overdose of Danircap 300 mg, they must immediately stop the drug and go to the nearest medical facility for timely treatment. Patients with an overdose of Danircap should receive symptomatic and supportive treatment. Hemodialysis may be beneficial in the event of an overdose of Danircap, especially in patients with impaired renal function.

7. Note when using the drug Danircap 300mg


Use caution when using Danircap in people with a history of allergy to penicillin, other antibiotics of the Cephalosporin group or other drugs. Use with caution in people with impaired renal function. Renal function must be checked before using the drug, if creatinine clearance is less than 30 ml/min, the dose must be reduced. During the use of the drug, it is also necessary to regularly monitor renal function. Danircap 300 mg should be used with caution in patients with a history of colitis. Long-term treatment with Danircap 300 mg may promote the development of non-susceptible organisms, or increase the incidence of antibiotic-resistant bacteria. Use caution when using Danircap 300mg for pregnant and lactating women. There are no data and studies on the efficacy and safety of Danircap when used in patients younger than 6 months. If an allergic reaction occurs when using Cefdinir, you must stop taking the drug and go to a medical facility for instructions on how to handle it. Danircap 300 may affect people who are operating machinery or driving. Danircap is a prescription drug, patients only take the drug as prescribed and directed by the doctor. If you need more information, consult your doctor or pharmacist to get the most out of your medication and avoid side effects.

Để đặt lịch khám tại viện, Quý khách vui lòng bấm số HOTLINE hoặc đặt lịch trực tiếp TẠI ĐÂY. Tải và đặt lịch khám tự động trên ứng dụng MyVinmec để quản lý, theo dõi lịch và đặt hẹn mọi lúc mọi nơi ngay trên ứng dụng.

8 lượt đọc

Dịch vụ từ Vinmec

Bài viết liên quan
  • SaViBroxol 30
    Công dụng thuốc SaViBroxol 30

    Thuốc SaViBroxol 30 được dùng để làm tiêu chất nhầy ở đường hô hấp. Thuốc có thành phần chính là Ambroxol HCl hàm lượng 30mg. Cùng tìm hiểu chi tiết hơn về công dụng, cách dùng và những lưu ý ...

    Đọc thêm
  • ho có đờm
    Ho khạc đờm lâu ngày điều trị như thế nào?

    Chào bác sĩ. Một năm trở lại đây tôi thường ho khạc đờm nhiều. Tôi có hút thuốc lá nhưng không nhiều. Mong bác sĩ tư vấn giúp tôi cách điều trị. Tôi xin cảm ơn bác sĩ.

    Đọc thêm
  • Floxsafe 400
    Công dụng thuốc Floxsafe 400

    Thuốc Floxsafe 400 có thành phần chính là Moxifloxacin và các thành phần tá dược khác. Thuốc được dùng trong điều trị viêm xoang cấp, viêm phế quản mạn, viêm phổi mắc phải ở cộng đồng, viêm da, viêm đường ...

    Đọc thêm
  • cagenine
    Công dụng thuốc Cagenine

    Thuốc Cagenine có chứa thành phần chính là Clarithromycin 500mg. Thuốc có công dụng điều trị viêm amidan, viêm xoang cấp, viêm tai giữa, viêm phế quản mạn có đợt cấp, nhiễm khuẩn da, mô mềm, viêm phổi, ho gà, ...

    Đọc thêm
  • Cefpova
    Công dụng của thuốc Cefpova

    Nhiễm trùng là một bệnh lý phổ biến do vi khuẩn gây ra, khi có sự nhiễm khuẩn thì cần được điều trị bằng kháng sinh. Trong đó, Cefpova là một loại kháng sinh phổ tác dụng rộng, thuộc nhóm ...

    Đọc thêm